Inner Mongolia Xinhao Pharmaceutical Technology Co., Ltd. was founded in November 2020, located in Wulanbuhe Industrial Park of High-tech Industrial Development Zone, which belongs to the beautiful "Camel Town" Alxa, with a registered capital of 50 million RMB and a total investment of about 660 million RMB. The project covers a total area of 165,300 square meters and a total construction area of 58,838.98 square meters.

The company adopts global advanced equipment, facilities and technology to develop and produce intermediates of guanidine salts, pharmaceutical APIs and related products; following the principle of "reducing, reusing and recycling", the company strives to build a resource recycling industrial system, comprehensively improve the resource utilization rate and establish a green and low-carbon circular development economic system.Calcium carbide and by-product carbon dioxide produced by China National Salt's Industry group are used as the main raw materials, and the annual consumption of carbon dioxide for production is 180,000 tons. No exhaust gas and waste water are generated during the production process, and only a small amount of waste residue is generated, which can be applied as a raw material for cement plants. It was listed by the Inner Mongolia Autonomous Region as one of the 2021 energy saving and emission reduction demonstration projects and one of the 100 key projects, which belongs to the national key promotion projects. After the completion of the project, the annual output value will reach 50,000 tons of dicyandiamide and, the sales revenue will be 700 million yuan.